Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Hallador Energy Shares Surge on Strong Quarterly Performance

Robert Sasse by Robert Sasse
November 29, 2025
in Analysis, Earnings, Energy & Oil, Trading & Momentum
0
Hallador Energy Stock
0
SHARES
35
VIEWS
Share on FacebookShare on Twitter

A substantial earnings beat and an improved analyst rating have propelled Hallador Energy into the spotlight. The company’s stock is currently trading at $20.39, reflecting a 2.51 percent gain, but the most compelling developments are found within its recent financial disclosures.

Exceptional Quarterly Results Drive Optimism

Hallador Energy’s third-quarter financial performance significantly surpassed market expectations, creating substantial positive momentum. The company reported earnings per share (EPS) of $0.55, dramatically exceeding the projected $0.06. Revenue figures told a similar story, with the company generating $146.85 million against forecasts of $110.92 million.

  • Earnings Surprise: $0.55 actual vs. $0.06 estimated
  • Revenue Performance: $146.85 million actual vs. $110.92 million forecast
  • Trailing Twelve-Month EPS Growth: 258%

This impressive showing has not gone unnoticed by market researchers, triggering a significant reassessment of the company’s prospects.

Analyst Rating Upgrade to “Strong-Buy”

In direct response to these robust financial results, Zacks Research has elevated its stance on Hallador Energy. The firm has upgraded its rating from “Hold” to “Strong-Buy,” signaling strong conviction in the stock’s potential for outperformance. This revision underscores a fundamentally improved outlook based on the company’s operational and financial execution.

Technical and Institutional Landscape

From a technical perspective, Chartmill awards Hallador Energy a solid rating of 7 out of 10, highlighting its “high growth momentum.” The shares are currently trading near a crucial support level between $19.11 and $19.46, with immediate resistance observed at $21.63. A decisive break above this resistance threshold could generate the trading volume needed to propel the stock toward higher price targets.

Should investors sell immediately? Or is it worth buying Hallador Energy?

Institutional investor activity presents a nuanced picture. On one hand, Corsair Capital Management L.P. established a new position by acquiring 30,000 shares, indicating growing confidence from sophisticated investors. Insider transactions have been mixed; Director Charles Ray Iv Wesley purchased 13,000 shares on November 21, while other insiders disposed of shares earlier in the quarter. Institutions collectively hold approximately 61.38% of the outstanding shares, providing a stable ownership base.

With a market capitalization of $893.59 million, Hallador represents a more volatile, smaller-cap investment compared to industry giants like Nucor and Newmont, but one with considerable potential for appreciation.

Market Outlook and Key Challenges

The current analyst consensus rating for the stock is “Moderate Buy,” accompanied by an average price target of $21.25. However, the recent “Strong-Buy” upgrade and favorable technical setup suggest the possibility of exceeding these projections.

The primary challenge for Hallador Energy through 2025 will be its ability to convert these substantial revenue beats into consistent positive net margins. With the current full-year EPS forecast standing at -0.31, achieving sustained profitability remains the most critical hurdle for the energy company to overcome.

Ad

Hallador Energy Stock: Buy or Sell?! New Hallador Energy Analysis from February 7 delivers the answer:

The latest Hallador Energy figures speak for themselves: Urgent action needed for Hallador Energy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Hallador Energy: Buy or sell? Read more here...

Tags: Hallador Energy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Next Post
Westamerica Bancorporation Stock

Westamerica Bancorporation Shares Defy Market Rally with Steep Decline

Blue Ridge Bankshares Stock

Blue Ridge Bankshares Emerges Strong with Triple Catalyst Surge

Apple Stock

Apple Stock: Analysts Project $320 Price Target as Rally Gains Momentum

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com